ROCHAL INDUSTRIES, LLP
Medtech · Private
Enzyme-based wound debridement formulation for removing necrotic tissue from burns and chronic ulcers
- Grants
- $571K
- 3 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $100K
- 1 award · Defense
- #523 of 4531 in medtech
- Patents
- 10
- 4 granted · 6 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201120122013201420152016
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | Department of Defense · SBIR Phase I 11.2 Army, Erms # 11255025, Proposal # A112-108-0079 | $99,880 | |
| Federal grant | Department of Health and Human Services · Phase I · Novel debridement for necrotic tissue | $216,045 | |
| Federal grant | Department of Health and Human Services · Phase I · Topical Microparticle Delivery for Burn Pain Control | $223,944 | |
| Federal grant | Department of Health and Human Services · Phase II · Injectable microgel for soft tissue repair | $130,541 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 520 | TRIBOFILM RESEARCH INC | $100K | — |
| 521 | PURACATH MEDICAL INC | $100K | $346K |
| 522 | Theranova LLC | $100K | — |
| 523 | ROCHAL INDUSTRIES, LLP | $100K | — |
| 524 | PROFUSA, INC. | $100K | $59M |
| 525 | Surfplasma, Inc. | $100K | — |
| 526 | Ionica Sciences, Inc | $100K | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Compositions And Kits For Enzymatic Debridement And Methods Of Using The Samegranted
- Compositions And Kits For Treating Pruritus And Methods Of Using The Sameapplication
- Composition And Kits For Inhibition Of Pathogenic Microbial Infection And Methods Of Using The Sameapplication
- Non-self-adherent Coating Materialsgranted
- Delivery Of Biologically-active Agents Using Volatile, Hydrophobic Solventsgranted
- Conformable Solvent-based Bandage And Coating Materialgranted
- Biocidal Compositions And Methods Of Using The Sameapplication
- Delivery Of Biologically-active Agents Using Volatile, Hydrophobic Solventsapplication
- Sacrificial Adhesive Coatingsapplication
- Conformable Bandage And Coating Materialapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.